256 related articles for article (PubMed ID: 32762368)
21. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.
Bessière F; Roccia H; Delinière A; Charrière R; Chevalier P; Argaud L; Cour M
JAMA Cardiol; 2020 Sep; 5(9):1067-1069. PubMed ID: 32936266
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk.
Offerhaus JA; Wilde AAM; Remme CA
Heart Rhythm; 2020 Sep; 17(9):1480-1486. PubMed ID: 32622993
[TBL] [Abstract][Full Text] [Related]
23. Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.
Seyhan AU; Doganay F; Yilmaz E; Topal NP; Ak R
J Coll Physicians Surg Pak; 2020 Oct; 30(10):153-157. PubMed ID: 33291194
[TBL] [Abstract][Full Text] [Related]
24. Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.
Moschini L; Loffi M; Regazzoni V; Di Tano G; Gherbesi E; Danzi GB
Heart Vessels; 2021 Jan; 36(1):115-120. PubMed ID: 32676695
[TBL] [Abstract][Full Text] [Related]
25. Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society.
Sapp JL; Alqarawi W; MacIntyre CJ; Tadros R; Steinberg C; Roberts JD; Laksman Z; Healey JS; Krahn AD
Can J Cardiol; 2020 Jun; 36(6):948-951. PubMed ID: 32299753
[TBL] [Abstract][Full Text] [Related]
26. Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.
Saleh M; Gabriels J; Chang D; Fishbein J; Qiu M; Mountantonakis SE; Epstein LM;
Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008937. PubMed ID: 33003964
[TBL] [Abstract][Full Text] [Related]
27. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
Giaime P; Guenoun M; Pedinielli N; Narbonne H; Bergounioux JP; Solas C; Guilhaumou R; Sampol J; Ollier J; Sichez H; Serveaux M; Brunner F; Bataille S
Nephrol Dial Transplant; 2020 Aug; 35(8):1346-1353. PubMed ID: 32844224
[TBL] [Abstract][Full Text] [Related]
28. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
[No Abstract] [Full Text] [Related]
29. Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
Voisin O; Lorc'h EL; Mahé A; Azria P; Borie MF; Hubert S; Ménage E; Guillerm JC; Mourad JJ
Mayo Clin Proc; 2020 Aug; 95(8):1696-1700. PubMed ID: 32753141
[TBL] [Abstract][Full Text] [Related]
30. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
Hor CP; Hussin N; Nalliah S; Ooi WT; Tang XY; Zachariah S; Jugindar Singh GPS; Abdul Rani R; Perumal K; Cheah WK
J Infect; 2020 Aug; 81(2):e117-e119. PubMed ID: 32474031
[No Abstract] [Full Text] [Related]
31. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
Gopinathannair R; Merchant FM; Lakkireddy DR; Etheridge SP; Feigofsky S; Han JK; Kabra R; Natale A; Poe S; Saha SA; Russo AM
J Interv Card Electrophysiol; 2020 Nov; 59(2):329-336. PubMed ID: 32494896
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
[TBL] [Abstract][Full Text] [Related]
33. Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with COVID-19 Treated with Hydroxychloroquine.
Asli R; Abdullah MS; Chong PL; Metussin D; Momin RN; Mani BI; Chong VH
Am J Trop Med Hyg; 2020 Jul; 103(1):79-82. PubMed ID: 32383430
[TBL] [Abstract][Full Text] [Related]
34. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
Gérard A; Romani S; Fresse A; Viard D; Parassol N; Granvuillemin A; Chouchana L; Rocher F; Drici MD;
Therapie; 2020; 75(4):371-379. PubMed ID: 32418730
[TBL] [Abstract][Full Text] [Related]
35. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703
[No Abstract] [Full Text] [Related]
36. Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19.
Schiavone M; Gasperetti A; Gherbesi E; Bergamaschi L; Arosio R; Mitacchione G; Viecca M; Forleo GB
Card Electrophysiol Clin; 2022 Mar; 14(1):95-104. PubMed ID: 35221089
[TBL] [Abstract][Full Text] [Related]
37. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
Bonow RO; Hernandez AF; Turakhia M
JAMA Cardiol; 2020 Sep; 5(9):986-987. PubMed ID: 32936259
[No Abstract] [Full Text] [Related]
38. QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
Diaz-Arocutipa C; Brañez-Condorena A; Hernandez AV
Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):694-706. PubMed ID: 33772933
[TBL] [Abstract][Full Text] [Related]
39. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
[TBL] [Abstract][Full Text] [Related]
40. Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019.
Jain S; Workman V; Ganeshan R; Obasare ER; Burr A; DeBiasi RM; Freeman JV; Akar J; Lampert R; Rosenfeld LE
Heart Rhythm; 2020 Sep; 17(9):1417-1422. PubMed ID: 32387247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]